These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4012134)

  • 21. [Treatment of hypertension with a delayed-action form of verapamil and its effect on hypertrophy and function of the left ventricle].
    Spacek R; Kozák P; Stárek A; Hes I; Skalníková V
    Vnitr Lek; 1987 Nov; 33(11):953-61. PubMed ID: 2964119
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the functional level of baroreceptors under the action of verapamil in arterial hypertension].
    Luna RL; Arslanian L; de Souza EM; de Oliveira PS
    Arq Bras Cardiol; 1988 Oct; 51(4):297-303. PubMed ID: 3251456
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
    Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
    Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of arterial hypertension with verapamil hydrochloride in patients after myocardial revascularization].
    Matiunin AV; Nikiforov IuV; Babaev OV
    Anesteziol Reanimatol; 2002; (6):49-51. PubMed ID: 12611158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies with sustained-release verapamil in essential hypertension.
    Silke B
    Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of verapamil in severe hypertension and hypertensive emergencies].
    Zanolli MB; Herdoiza GL; Padolan E; Mulinari AS; Lassitte A; Branco BP; Marks SC; Rocha de Carvalho JG
    Arq Bras Cardiol; 1982 Sep; 39(3):193-6. PubMed ID: 7186365
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions.
    Aarons L; Baxter C; Gupta S
    Biopharm Drug Dispos; 2004 Jul; 25(5):219-25. PubMed ID: 15248191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A; de Albuquerque EM; Reynaldo Stella S; Draibe SA; Ajzen H
    Arq Bras Cardiol; 1983 Jan; 40(1):69-71. PubMed ID: 6351814
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immediate effect of verapamil in hypertensive cardiopathy].
    Manfroi WC; Vieira SR; Ludwig R; Hemb R; de Azevedo DF; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1982 Dec; 39(6):417-20. PubMed ID: 6764615
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.
    Lenz ML; Pool JL; Laddu AR; Varghese A; Johnston W; Taylor AA
    Am J Hypertens; 1995 Feb; 8(2):133-45. PubMed ID: 7755941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapy.
    Rubio-Guerra AF; Lozano-Nuevo JJ; Vargas-Ayala G; Rodríguez-López L; Ramos-Brizuela LM; Escalante-Acosta BA
    Clin Exp Hypertens; 2006 Oct; 28(7):619-24. PubMed ID: 17060060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
    Cedro K; Dłuzniewski M; Szpytma M
    Wiad Lek; 1993 Dec; 46(23-24):885-92. PubMed ID: 7900383
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of hydralazine, in conventional and slow-release preparations, during long-term treatment of primary hypertension.
    Lins LE; Berglund J; Eliasson K; Wernersson B
    Clin Ther; 1983; 5(3):251-9. PubMed ID: 6850719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension.
    Reinfrank J; Eckardt A; Hahn KJ
    Bibl Cardiol; 1987; (42):156-60. PubMed ID: 3307756
    [No Abstract]   [Full Text] [Related]  

  • 40. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
    Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
    Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.